Our studying showed that miR-138-5p targeted PD-L1 to down-regulate PD-L1 in NSCLC and reduce the inhibitory effects on DCs, promote CTL–mediated killing of tumor cells, and increase the proliferation of T cells. Here, CD274 is linked to neoplasm.